Erasca Management
Management criteria checks 2/4
Erasca's CEO is Jonathan Lim, appointed in Jul 2018, has a tenure of 5.75 years. total yearly compensation is $7.52M, comprised of 7.9% salary and 92.1% bonuses, including company stock and options. directly owns 21.41% of the company’s shares, worth $59.86M. The average tenure of the management team and the board of directors is 2.9 years and 5.5 years respectively.
Key information
Jonathan Lim
Chief executive officer
US$7.5m
Total compensation
| CEO salary percentage | 7.9% |
| CEO tenure | 5.8yrs |
| CEO ownership | 21.4% |
| Management average tenure | 2.9yrs |
| Board average tenure | 5.5yrs |
Recent management updates
Recent updates
Is Erasca (NASDAQ:ERAS) In A Good Position To Deliver On Growth Plans?
Feb 21
We Think Erasca (NASDAQ:ERAS) Needs To Drive Business Growth Carefully
Nov 16Companies Like Erasca (NASDAQ:ERAS) Are In A Position To Invest In Growth
Jun 28We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth
Jan 20Erasca forms clinical trial partnership with Pfizer for cancer therapy
Oct 20Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation
Sep 23Erasca adds 10% ahead of R&D Day
Sep 07Erasca, Eli Lilly to collaborate on trial to evaluate combo treatment for two cancers
Jul 18We're Not Very Worried About Erasca's (NASDAQ:ERAS) Cash Burn Rate
Apr 12Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation
Dec 28CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$125m |
| Sep 30 2023 | n/a | n/a | -US$231m |
| Jun 30 2023 | n/a | n/a | -US$236m |
| Mar 31 2023 | n/a | n/a | -US$240m |
| Dec 31 2022 | US$8m | US$593k | -US$243m |
| Sep 30 2022 | n/a | n/a | -US$138m |
| Jun 30 2022 | n/a | n/a | -US$149m |
| Mar 31 2022 | n/a | n/a | -US$141m |
| Dec 31 2021 | US$850k | US$498k | -US$123m |
| Sep 30 2021 | n/a | n/a | -US$154m |
| Jun 30 2021 | n/a | n/a | -US$119m |
| Mar 31 2021 | n/a | n/a | -US$96m |
| Dec 31 2020 | US$2m | US$300k | -US$102m |
Compensation vs Market: Jonathan's total compensation ($USD7.52M) is above average for companies of similar size in the US market ($USD1.60M).
Compensation vs Earnings: Jonathan's compensation has increased whilst the company is unprofitable.
CEO
Jonathan Lim (51 yo)
5.8yrs
Tenure
US$7,523,335
Compensation
Dr. Jonathan E. Lim, M.D. co-founded Erasca, Inc. in July 2018 and has been its Executive Chairman since October 2018 and Chief Executive Officer since March 2019. Dr. Lim has also served as a Venture Part...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 5.8yrs | US$7.52m | 21.41% $ 59.9m | |
| CFO & Chief Business Officer | 3.3yrs | US$3.66m | 0.16% $ 456.4k | |
| Chairman of Research & Development | 3.7yrs | US$314.13k | 0% $ 0 | |
| Chief Operating Officer | 2.9yrs | no data | no data | |
| General Counsel & Corporate Secretary | 3yrs | US$2.98m | 0.0064% $ 18.0k | |
| Chief People Officer | 2.3yrs | no data | no data | |
| Senior Vice President of Finance | 2.9yrs | no data | no data | |
| Chief Regulatory Affairs Officer | 2.9yrs | no data | no data | |
| Senior Vice President of Research | 2.4yrs | no data | no data | |
| Chief Medical Officer | 1.9yrs | no data | no data | |
| Senior Vice President of Pharmaceutical Development & Operations | 1.4yrs | no data | no data | |
| Senior Vice President of Clinical Pharmacology | less than a year | no data | no data |
2.9yrs
Average Tenure
51.5yo
Average Age
Experienced Management: ERAS's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 5.5yrs | US$7.52m | 21.41% $ 59.9m | |
| Chairman of Research & Development | 3.7yrs | US$314.13k | 0% $ 0 | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Independent Director | 5.8yrs | US$208.91k | 0.39% $ 1.1m | |
| Independent Director | 5.8yrs | US$197.91k | 0.11% $ 319.8k | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Independent Director | 5.8yrs | US$207.91k | 0.14% $ 383.9k | |
| Independent Director | 3.1yrs | US$206.41k | 0.0040% $ 11.1k | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Independent Director | 4.8yrs | US$206.91k | 0.015% $ 40.7k | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Scientific Advisory Board Member | no data | no data | no data |
5.5yrs
Average Tenure
64yo
Average Age
Experienced Board: ERAS's board of directors are considered experienced (5.5 years average tenure).